Global Mycoplasma Testing Market to Witness a CAGR of 12.3% during 2018-2024
27 juil. 2018 10h13 HE
|
Energias Market Research
NEW YORK, July 27, 2018 (GLOBE NEWSWIRE) -- The global mycoplasma testing market was valued at USD 606.9 million in 2017, and is expected to reach USD 1358.2 million by 2024, at a CAGR of 12.3%...
Horizon Pharma plc and the National Organization for Rare Disorders (NORD) Illustrate 35 years of Progress in Rare Disease at the Biotechnology Innovation Organization (BIO) International Convention
04 juin 2018 08h00 HE
|
Horizon Pharma plc
-- People can join the campaign by texting the word “RARE” to 56512, which generates a donation to NORD -- DUBLIN, Ireland, June 04, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP) and...
Horizon Pharma plc Reports Strong First-Quarter 2018 Orphan and Rheumatology Net Sales Growth; Increases Full-Year 2018 Guidance and Announces New Company Operating Structure to Enhance Focus on Rare Diseases
09 mai 2018 07h00 HE
|
Horizon Pharma plc
-- First-Quarter 2018 Orphan and Rheumatology Net Sales of $172.2 Million Increased 11 Percent;Represented 77 Percent of Total Company Net Sales -- -- First-Quarter 2018 KRYSTEXXA Net Sales Growth of...
Singular Research Initiates Coverage On EVIO
25 avr. 2018 08h00 HE
|
EVIO, Inc.
BEND, Ore., April 25, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – EVIO, Inc. (OTCQB:EVIO) (“EVIO” or “the Company”), today announced that Singular Research has initiated analyst coverage on the...
CannabisNewsWire Announces Publication on Innovative Technology and Advances in Cannabis Biotech
04 avr. 2018 08h30 HE
|
CannabisNewsWire
NEW YORK, April 04, 2018 (GLOBE NEWSWIRE) -- via CannabisNewsWire – CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial...
CannabisNewsWire Announces Publication on Continued Efforts to Improve Healthcare Through Cannabis
02 avr. 2018 08h30 HE
|
CannabisNewsWire
NEW YORK, April 02, 2018 (GLOBE NEWSWIRE) -- via CannabisNewsWire – CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial...
Minerva Neurosciences Reports Fiscal 2017 Fourth Quarter and Year End Financial Results and Business Updates
12 mars 2018 07h30 HE
|
Minerva Neurosciences, Inc
Four late-stage trials underway, targeting schizophrenia, major depressive disorder and insomnia disorder Planning for commercialization moves forward Management to host conference call today at...
Molecular Templates Closes $10 Million Debt Facility with Perceptive Advisors
02 mars 2018 16h30 HE
|
Molecular Templates, Inc.
AUSTIN, Texas, March 02, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq:MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin...
Horizon Pharma plc Announces Fourth-Quarter and Full-Year 2017 Results
28 févr. 2018 07h00 HE
|
Horizon Pharma plc
-- Fourth-Quarter 2017 Net Sales of $274.2 Million;Fourth-Quarter 2017 Net Loss of $46.4 Million; Adjusted EBITDA of $102.7 Million -- -- Fourth-Quarter 2017 Operating Cash Flow of $143.2 Million;...
Portola Pharmaceuticals to Announce Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on Wednesday, February 28, 2018
15 févr. 2018 16h05 HE
|
Portola Pharmaceuticals, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc.® (NASDAQ:PTLA) today announced that it will host a webcast and conference call to discuss the Company’s...